ICCC

6.495

1.14% -0.075

Handel nachbörslich: 6.57 0.075 +1.15%

Immucell Corp (ICCC)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$6.57

Offen:

$6.6

24-Stunden-Volumen:

19,760

Relative Volume:

0.77

Marktkapitalisierung:

$58.75M

Einnahmen:

$23.84M

Nettoeinkommen (Verlust:

$-3.81M

KGV:

-12.99

EPS:

-0.5

Netto-Cashflow:

$-713.00K

1W Leistung:

+9.71%

1M Leistung:

+16.61%

6M Leistung:

-3.78%

1J Leistung:

+25.63%

1-Tages-Spanne:

$6.495

$6.8921

1-Wochen-Bereich:

$5.80

$6.8921

52-Wochen-Spanne:

$4.28

$7.60

Immucell Corp Stock (ICCC) Company Profile

Firmenname

Immucell Corp

Sektor

Healthcare (1115)

Branche

Biotechnology (621)

Telefon

(207) 878-2770

Adresse

56 EVERGREEN DR, PORTLAND, ME

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-11-13

Neueste SEC-Einreichungen

ICCC's Discussions on Twitter

Vergleichen Sie ICCC mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ICCC Immucell Corp	6.495	59.43M	23.84M	-3.81M	-713.00K	-0.50
VRTX Vertex Pharmaceuticals Inc	463.86	119.17B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	796.55	84.19B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	398.29	52.77B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	788.49	48.98B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	175.97	36.31B	447.02M	-1.18B	-906.14M	-6.1812

Immucell Corp Aktie (ICCC) Neueste Nachrichten

Jan 09, 2026

Earnings call transcript: ImmuCell Q4 2025 sees positive stock movement - Investing.com

Jan 09, 2026

Jan 08, 2026

Is ImmuCell Corporation stock resilient to inflationQuarterly Trade Summary & Precise Trade Entry Recommendations - ulpravda.ru

Jan 08, 2026

ImmuCell reports Q4 sales of $7.6 million, shifts focus to First Defense - Investing.com

Jan 08, 2026

Macro Review: Is ImmuCell Corporation stock near bottom after declineJuly 2025 Pullbacks & Real-Time Buy Zone Alerts - ulpravda.ru

Jan 08, 2026

How rising interest rates impact ImmuCell Corporation stockCPI Data & Daily Market Momentum Tracking - ulpravda.ru

Jan 08, 2026

Will ImmuCell Corporation stock maintain dividend yieldJuly 2025 Short Interest & Trade Opportunity Analysis Reports - ulpravda.ru

Jan 08, 2026

Jan 07, 2026

ImmuCell Corporation Announces Investor Conference Call to Discuss Strategic Shift and Q4 2025 Sales Results - Quiver Quantitative

Jan 07, 2026

Cattle firm ImmuCell shifts focus to calf product, previews 2025 sales - Stock Titan

Jan 07, 2026

Dec 28, 2025

The Christmas party is still ongoing in these stocks: Nvidia, Sidus Space, Coupang, Vanda Pharmaceuticals, ImmuCell - MSN

Dec 28, 2025

Dec 26, 2025

The Christmas Party Is Still Ongoing In These Stocks: Nvidia, Sidus Space, Coupang, Vanda Pharmaceuticals, ImmuCell - Stocktwits

Dec 26, 2025

ImmuCell Puts Re-Tain On Pause After FDA Letter - Benzinga

Dec 26, 2025

The Zacks Analyst Blog AbbVie, The Coca-Cola, Chevron, ImmuCell and Precipio - sharewise.com

Dec 26, 2025

Dec 24, 2025

12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga

Dec 24, 2025

Top Stock Reports for AbbVie, Coca-Cola & Chevron - sharewise.com

Dec 24, 2025

ImmuCell shifts focus to First Defense after FDA setback for Re-Tain By Investing.com - Investing.com South Africa

Dec 24, 2025

ImmuCell shifts focus to First Defense after FDA setback for Re-Tain - Investing.com

Dec 24, 2025

ImmuCell Corporation Receives Incomplete FDA Letter for Re-Tain® NADA and Expands First Defense® Sales Force by 50% - Quiver Quantitative

Dec 24, 2025

How a $900M calf-health market is reshaping this Maine animal company - Stock Titan

Dec 24, 2025

Dec 20, 2025

Will ImmuCell Corporation stock outperform Dow Jones indexJuly 2025 Big Picture & Free Weekly Chart Analysis and Trade Guides - Улправда

Dec 20, 2025

Dec 19, 2025

Why ImmuCell Corporation stock is popular among millennialsQuarterly Market Review & Long-Term Capital Growth Strategies - Улправда

Dec 19, 2025

Dec 18, 2025

Can ImmuCell Corporation stock maintain operating marginsPortfolio Growth Summary & High Return Trade Guides - ulpravda.ru

Dec 18, 2025

ImmuCell Corporation's (NASDAQ:ICCC) Price Is Right But Growth Is Lacking After Shares Rocket 34% - simplywall.st

Dec 18, 2025

Dec 16, 2025

ImmuCell (NASDAQ:ICCC) Stock Passes Below 200-Day Moving AverageWhat's Next? - MarketBeat

Dec 16, 2025

Dec 11, 2025

ImmuCell (NASDAQ:ICCC) delivers shareholders 27% return over 1 year, surging 13% in the last week alone - simplywall.st

Dec 11, 2025

Dec 04, 2025

Insider Buying: te Boekhorst Paul Francis Olivier Acquires Additional Shares of ImmuCell Corp (ICCC) - GuruFocus

Dec 04, 2025

ImmuCell's Two-Product Edge in Cattle Health Fuels Growth - Finviz

Dec 04, 2025

Bull Run: Will ImmuCell Corporation stock maintain dividend yieldTrade Risk Report & Weekly Hot Stock Watchlists - moha.gov.vn

Dec 04, 2025

Will ImmuCell Corporation (IUL) stock benefit from sector leadershipJuly 2025 Sector Moves & Free Safe Capital Growth Stock Tips - Newser

Dec 04, 2025

Dec 03, 2025

ImmuCell Corp President and CEO Acquires 9,785 Shares - TradingView — Track All Markets

Dec 03, 2025

Dec 02, 2025

Will ImmuCell Corporation stock continue dividend increasesMarket Sentiment Summary & Verified Technical Trade Signals - Newser

Dec 02, 2025

Will ImmuCell Corporation stock deliver consistent dividends2025 EndofYear Setup & Technical Confirmation Alerts - Newser

Dec 02, 2025

Is ImmuCell Corporation (IUL) stock a buy before earnings resultsJuly 2025 Volume & Free Technical Confirmation Trade Alerts - Newser

Dec 02, 2025

Is ImmuCell Corporation (IUL) stock a fit for income portfoliosJuly 2025 Market Mood & Daily Oversold Stock Bounce Ideas - Newser

Dec 02, 2025

Nov 28, 2025

ImmuCell (ICCC) director Tomsche buys shares worth $15,554 By Investing.com - Investing.com Canada

Nov 28, 2025